A Prospective Study for Introducing Insulin Pens and Safety Needles in a Hospital Setting. The SANITHY Study
| Autor: | Bruno Ferraro, Alessandra Braus, Maurizio Destro, Sara Madaschi, Carmine S. Poerio, Estella M. Davis, Giovanni Veronesi, Paolo Sganzerla, Antonio Bossi, Lavinia Gilberti |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
Male
medicine.medical_specialty safety devices Needlestick injury Endocrinology Diabetes and Metabolism medicine.medical_treatment Injections Subcutaneous 030209 endocrinology & metabolism Vial Article insulin therapy costs 03 medical and health sciences 0302 clinical medicine Endocrinology Patient satisfaction Diabetes mellitus medicine Humans Hypoglycemic Agents Insulin safety needles 030212 general & internal medicine Prospective cohort study Syringe Aged Inpatients insulin therapy Aged 80 and over business.industry customer satisfaction Syringes Insulin pen insulin pens Middle Aged medicine.disease Surgery Hospitalization Diabetes Mellitus Type 2 Italy Needles Patient Satisfaction Hyperglycemia Emergency medicine Female business |
| Zdroj: | Current Diabetes Reviews |
| Popis: | Background: to assess costs and safety of insulin pen devices and safety needles as compared to vial/syringes in hospitalized patients requiring insulin therapy in a General Hospital in Northern Italy. Materials and Methods: in a prospective 9-month study, consecutive patients admitted to three Hospital Units received insulin therapy through either a traditional disposable syringe method, or pen/safety needles with dual-ended protection, or disposable safety syringes. We compared the median direct (insulin and devices) and indirect (insulin supply at discharge, insulin wastage) costs of a 10-day in-hospital insulin treatment in the 3 study groups, additionally accounting for the costs related to the observed needlestick injury rate. Patients’ safety during in-hospital stay (hypo- and hyperglycemia episodes) and satisfaction were also assessed. Results: N=360 patients (55% men, mean age 75.6 years, 57% with DM since ≥10 years) were recruited in the study. Insulin pens had higher median direct cost than both traditional syringes (43 vs. 18 e/patient, p |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|